NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRBO NeuroBo Pharmaceuticals, Inc.

休市中 05-03 16:00:00 EDT

3.78

+0.05

+1.34%

盘后3.78

+0.000.00%

17:25 EDT

最高3.80	最低3.60	成交量2.21万
今开3.67	昨收3.73	日振幅5.35%
总市值1,854万	流通市值1,782万	总股本490.60万
成交额8.24万	换手率0.47%	流通股本471.39万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRBO","market":"US","secType":"STK","nameCN":"NeuroBo Pharmaceuticals, Inc.","latestPrice":3.78,"timestamp":1714766400000,"preClose":3.73,"halted":0,"volume":22131,"hourTrading":{"tag":"盘后","latestPrice":3.78,"preClose":3.78,"latestTime":"17:25 EDT","volume":22,"amount":79.42,"timestamp":1714771503160},"delay":0,"floatShares":4713877,"shares":4906002,"eps":-2.459999,"marketStatus":"休市中","marketStatusCode":7,"change":0.05,"latestTime":"05-03 16:00:00 EDT","open":3.67,"high":3.7997,"low":3.6,"amount":82415.8108035,"amplitude":0.053539,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.459999,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1470369600000,"adjPreClose":3.73,"postHourTrading":{"tag":"盘后","latestPrice":3.78,"preClose":3.78,"latestTime":"17:25 EDT","volume":22,"amount":79.42,"timestamp":1714771503160},"volumeRatio":0.753529},"requestUrl":"/m/hq/s/NRBO/wiki","defaultTab":"wiki","newsList":[{"id":"2432305156","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨5.26%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432305156","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432305156?lang=zh_cn&edition=full","pubTime":"2024-05-01 01:06","pubTimestamp":1714496785,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日01时06分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.26%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Eliem Therapeutics, Inc、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1452.72%、231.33%、27.46%，振幅较大的相关个股有Eliem Therapeutics, Inc、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为55.38%、48.00%、46.79%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010106257a57c9cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010106257a57c9cc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429921936","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429921936","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429921936?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:39","pubTimestamp":1713793153,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时39分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.53%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Moolec Science Sa、Adial Pharmaceuticals, Inc、亚狮康药业较为活跃，换手率分别为115.91%、46.99%、37.27%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、亚狮康药业，振幅分别为144.06%、30.71%、18.71%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221391479225653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221391479225653&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428345644","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨8.53%报3.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345644","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428345644?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360713,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速上涨8.53%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.、Viracta Therapeutics, Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.43%、21.99%、17.23%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Viracta Therapeutics, Inc.、Vanda Pharmaceuticals Inc.，振幅分别为25.29%、15.75%、12.10%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213153878a137b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213153878a137b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428931804","title":"Neurobo Pharmaceuticals, Inc.盘中异动 大幅下跌5.67%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428931804","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428931804?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:20","pubTimestamp":1713295242,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时20分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.67%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Jaguar Health, Inc.、Finch Therapeutics Group, Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为3324.70%、259.57%、206.37%，振幅较大的相关个股有Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.，振幅分别为103.61%、101.94%、97.81%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041703204287e81073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041703204287e81073&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427753032","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨8.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427753032","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427753032?lang=zh_cn&edition=full","pubTime":"2024-04-13 01:36","pubTimestamp":1712943411,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日01时36分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速上涨8.94%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.47%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3626.29%、1424.94%、96.01%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、73.57%、58.59%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130136517a527b3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130136517a527b3f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426119145","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大跌6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119145","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426119145?lang=zh_cn&edition=full","pubTime":"2024-04-09 23:15","pubTimestamp":1712675711,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日23时15分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速跳水6.80%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Acrivon Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Vbi Vaccines, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为456.14%、104.98%、78.82%，振幅较大的相关个股有Mymd Pharmaceuticals, Inc.、Biophytis、Cadrenal Therapeutics, Inc.，振幅分别为45.14%、40.61%、36.75%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092315127a51a8b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404092315127a51a8b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424076076","title":"Neurobo Pharmaceuticals, Inc.盘中异动 大幅下跌5.17%报3.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424076076","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424076076?lang=zh_cn&edition=full","pubTime":"2024-04-03 02:59","pubTimestamp":1712084348,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日02时59分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.17%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.68%。其相关个股中，Gamida Cell Ltd.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Q32 Bio Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为930.64%、165.23%、68.04%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、Gamida Cell Ltd.，振幅分别为104.31%、67.61%、61.39%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403025908791e82b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403025908791e82b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423129271","title":"NeuroBo 制药公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2423129271","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2423129271?lang=zh_cn&edition=full","pubTime":"2024-03-29 05:02","pubTimestamp":1711659765,"startTime":"0","endTime":"0","summary":"   * NeuroBo Pharmaceuticals Inc   报告了截至12月底的季度调整后每股亏损2.28美元，高于去年同期的每股收益14.56美元。两位分析师对该季度的平均预期是每股亏损 78 美分。华尔街预期为每股-84美分至-73美分。* NeuroBo Pharmaceuticals Inc 公布的季度每股收益为亏损 2.28 美元。* 该公司当季亏损 531 万美元。* NeuroBo Pharmaceuticals Inc 的股价本季度上涨了 17.4%。* 华尔街对 NeuroBo Pharmaceuticals Inc 的 12 个月目标价中位数为 36.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422621021","title":"NeuroBo Pharmaceuticals Inc    预计每股亏损 78 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422621021","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422621021?lang=zh_cn&edition=full","pubTime":"2024-03-27 04:15","pubTimestamp":1711484110,"startTime":"0","endTime":"0","summary":"   * NeuroBo Pharmaceuticals Inc    预计在3月28日公布截至2023年12月31日的业绩时，季度收入将没有变化()    *    * LSEG的分析师平均预计NeuroBo Pharmaceuticals Inc每股亏损78美分。* 分析师对该公司股票的评级为 \"强力买入\"。* 华尔街对 NeuroBo Pharmaceuticals Inc 的 12 个月目标价中位数为 36.50 美元，高于其上次收盘价 4.39 美元。3月26日 - 本摘要于北京时间 3 月 26 日 20:15 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420003642","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘大幅下挫5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420003642","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420003642?lang=zh_cn&edition=full","pubTime":"2024-03-20 04:01","pubTimestamp":1710878469,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日04时01分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.30%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Fusion Pharmaceuticals Inc.、Nkgen Biotech Inc C/Wts 31/05/2028、Enliven Therapeutics, Inc.涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为950.74%、447.37%、408.68%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Moolec Science Sa C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 ，振幅分别为95.79%、83.33%、75.79%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403200401107a4db913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403200401107a4db913&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420284048","title":"Neurobo Pharmaceuticals, Inc.盘中异动 快速下跌5.00%报4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420284048","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420284048?lang=zh_cn&edition=full","pubTime":"2024-03-19 03:34","pubTimestamp":1710790469,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日03时34分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.00%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319033429791b39d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319033429791b39d8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417290036","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417290036","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417290036?lang=zh_cn&edition=full","pubTime":"2024-03-06 23:02","pubTimestamp":1709737320,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日23时02分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.41%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Biomx Inc.、知临集团、Nkgen Biotech, Inc.涨幅较大，知临集团、Creative Medical Technology Holdings, Inc.、Biomx Inc.较为活跃，换手率分别为181.43%、177.68%、173.83%，振幅较大的相关个股有Biomx Inc.、知临集团、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为93.03%、74.26%、70.90%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段的生物技术公司，主要专注于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306230200861dbd7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240306230200861dbd7d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurobopharma.com","stockEarnings":[{"period":"1week","weight":0.2038},{"period":"1month","weight":-0.0283},{"period":"3month","weight":-0.2632},{"period":"6month","weight":0.125},{"period":"1year","weight":-0.2125},{"period":"ytd","weight":0.0226}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroBo Pharmaceuticals, Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。NeuroBo Pharmaceuticals, Inc.是一家临床阶段的生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新药物。NeuroBo有两个主要项目，重点治疗非酒精性脂肪性肝炎（NASH）、肥胖症和2型糖尿病（T2D）。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.101843},{"month":2,"riseRate":0.375,"avgChangeRate":0.080599},{"month":3,"riseRate":0.5,"avgChangeRate":-0.020088},{"month":4,"riseRate":0.375,"avgChangeRate":-0.098642},{"month":5,"riseRate":0.25,"avgChangeRate":-0.105909},{"month":6,"riseRate":0.571429,"avgChangeRate":0.079355},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.00289},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.23779},{"month":9,"riseRate":0.375,"avgChangeRate":0.039055},{"month":10,"riseRate":0.125,"avgChangeRate":-0.215957},{"month":11,"riseRate":0.375,"avgChangeRate":-0.112459},{"month":12,"riseRate":0.125,"avgChangeRate":-0.172588}],"exchange":"NASDAQ","name":"NeuroBo Pharmaceuticals, Inc.","nameEN":"NeuroBo Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeuroBo Pharmaceuticals, Inc.,NRBO,NeuroBo Pharmaceuticals, Inc.股票,NeuroBo Pharmaceuticals, Inc.股票老虎,NeuroBo Pharmaceuticals, Inc.股票老虎国际,NeuroBo Pharmaceuticals, Inc.行情,NeuroBo Pharmaceuticals, Inc.股票行情,NeuroBo Pharmaceuticals, Inc.股价,NeuroBo Pharmaceuticals, Inc.股市,NeuroBo Pharmaceuticals, Inc.股票价格,NeuroBo Pharmaceuticals, Inc.股票交易,NeuroBo Pharmaceuticals, Inc.股票购买,NeuroBo Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况